Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Emyria Ltd ( (AU:EMD) ).
Emyria Limited has announced that Tattarang Ventures Pty Ltd, along with associated entities, has ceased to be a substantial holder in the company as of June 26, 2025. This change was due to the dilution of shares following the issuance of fully paid ordinary shares pursuant to a placement, affecting 23,817,777 shares. This development may impact Emyria’s shareholder structure and could influence its market positioning and stakeholder interests.
More about Emyria Ltd
Emyria Limited operates in the healthcare industry, focusing on the development of innovative medical treatments and technologies. The company primarily engages in providing solutions that enhance patient care and outcomes, with a market focus on leveraging cutting-edge research and development to address unmet medical needs.
Average Trading Volume: 1,289,501
Technical Sentiment Signal: Sell
Current Market Cap: A$16.51M
Learn more about EMD stock on TipRanks’ Stock Analysis page.